ALEXANDRIA, Va., Feb. 3 -- United States Patent no. 12,539,287, issued on Feb. 3, was assigned to Iowa State University Research Foundation Inc. (Ames, Iowa) and Board of Regents, The University of Texas System (Austin, Texas).

"L-DOPA microbiome therapy" was invented by Anumantha G. Kanthasamy (Ames, Iowa), Ahmed Abdalla (Ames, Iowa), Gregory Phillips (Ames, Iowa), Nicholas Backes (Ames, Iowa), Andrew D. Ellington (Austin, Texas) and Ross Thyer (Austin, Texas).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention generally provides methods and compositions for the treatment of Parkinson's disease and depression and/or anxiety. The invention relates to recombinant microorganisms, particularly g...